Loading...
XFRA
B4V
Market cap106mUSD
, Last price  
EUR
Name

Arcticzymes Technologies ASA

Chart & Performance

D1W1MN
XFRA:B4V chart
P/E
—
P/S
—
EPS
0.17
Div Yield, %
—
Shrs. gr., 5y
2.01%
Rev. gr., 5y
6.20%
Revenues
104m
-12.26%
70,041,00072,973,00073,217,00051,702,00024,075,00025,909,00023,032,00021,475,00022,108,00033,026,00053,280,00071,904,00066,686,00066,769,00077,247,00093,449,000127,970,000136,971,000118,939,000104,352,000
Net income
8m
-56.40%
-15,446,000-26,654,000-18,665,000-52,179,000-99,372,000-28,541,000-20,103,000-24,318,000-22,889,000-21,992,000-17,344,000-20,480,000-24,938,000-13,989,000-7,183,00083,119,00046,380,00032,860,00019,425,0008,470,000
CFO
2m
-93.21%
-8,468,000-32,590,0000-65,657,000-89,000,000-24,965,000-10,811,000-24,583,000-17,385,000-21,200,000-12,886,000-19,278,000-22,056,000-18,279,0003,965,00046,928,00074,970,00058,094,00024,430,0001,659,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

ArcticZymes Technologies ASA, a life sciences company, develops, manufactures, and commercializes recombinant enzymes for use in molecular research, In vitro diagnostics, and biomanufacturing. It offers salt active nuclease for the removal of nucleic acids during manufacturing of viral vectors, recombinant proteins, and other reagents; shrimp alkaline phosphatase and derived kits for cleanup prior to Sanger sequencing and next generation sequencing processes; cod UNG for use in viral and other molecular diagnostic assays; double-strand specific DNases and derived kits for the removal of double stranded DNA; polymerases for technology development for life science, molecular diagnostics, NGS, and synthetic biology; proteinase for microbiological diagnostics and liquid biopsies; and ligases for joining DNA /RNA fragments. It operates in Norway, Germany, Lithuania, Italy, other countries in Europe, the United States, and internationally. The company was formerly known as Biotec Pharmacon ASA and changed its name to ArcticZymes Technologies ASA in June 2020. ArcticZymes Technologies ASA was incorporated in 1990 and is headquartered in Tromsø, Norway.
URL
https://arcticzymes.com/
IPO date
Nov 04, 2005
Employees
60
Domiciled in
NO
Incorporated in
NO

Valuation

Title
NOK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT